Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CC-5079

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A series of 1,1-diarylalkene derivatives were prepared to optimize the properties of CC-5079 (1), a dual inhibitor of tubulin… Expand
Is this relevant?
2010
2010
INTRODUCTION CC-5079, a small molecule inhibitor of tubulin polymerization and phosphodiesterase-4 activity, was evaluated for… Expand
Is this relevant?
2008
2008
During studies on the alkenyldiarylmethane (ADAM) class of non-nucleoside reverse transcriptase inhibitors (NNRTIs), analogues… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
We have found that the synthetic compound CC-5079 potently inhibits cancer cell growth in vitro and in vivo by a novel… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?